• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Lifestyle interventions can reduce type 2 diabetes among high-risk patients

bys25qthea
October 15, 2013
in Chronic Disease, Endocrinology
Reading Time: 3 mins read
Updated USPSTF guidelines favor treatment of mild gestational diabetes
Share on FacebookShare on Twitter

Image: PD 

1. Based on this systematic review, the use of comprehensive lifestyle interventions significantly reduced the incidence of Type 2 diabetes mellitus (DM) among high-risk patients. 

2.  There is insufficient evidence to support the benefit of lifestyle interventions on cardiovascular or microvascular outcomes among patients with already established Type 2 DM. 

Evidence Rating Level: 1 (Excellent) 

Study Rundown: Type 2 DM is an increasingly prevalent disease and a leading cause of death in the United States.  This recent systematic meta-analysis assessed the impact of comprehensive lifestyle interventions in both patient populations at risk for Type 2 DM as well as patients with an already established diagnosis of Type 2 DM.  In this study, two independent researchers selected 20 unique studies for analysis. The analysis found that among patients that are high risk, diet and exercise lifestyle interventions were associated with a statistically significant decrease in the development of Type 2 DM. However, there was not sufficient evidence to demonstrate benefit in cardiovascular outcome in this patient population.  Among the patients with an established diagnosis of Type 2 DM, the analysis did not find evidence to support lifestyle interventions in improving all-cause mortality, cardiovascular outcomes and microvascular complications.  Overall, this systematic analysis provided moderate evidence to support lifestyle intervention for prevention in type II DM in high risk patients, but its results did not suggest a benefit for its application in patients with an already established diagnosis of Type 2 DM.

Click to read the study, published today in the Annals of Internal Medicine

RELATED REPORTS

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

Relevant Reading: Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes

In-Depth [systematic review]: Two independent reviewers screened 1289 studies to find RCTs that tested the efficacy of lifestyle interventions, defined as a combination of diet, exercise, and at least one other component, in adults who had or were at risk to develop type 2 diabetes.  The primary outcomes were death, CVD, and microvascular complications, and secondary outcomes were markers of diabetic progression, such as hemoglobin A1C.  Among the 9 studies with high risk patients, 7 reported a statistically significant decrease in the development of type 2 diabetes, together with a risk ratio (RR) of 0.35 (p=0.02) at the end of intervention, which was maintained at follow up at 10 years (RR=0.80, p<0.001).  The effect on CVD and other complications was not statistically significant.  Among the 11 studies of patients with type 2 diabetes, there was a statistically insignificant trend towards decreased mortality with lifestyle interventions (RR=0.75, p=0.11).  Other primary and secondary outcomes did not show statistically significant differences.  The major weaknesses of this review was the low number of selected studies and an unknown degree of confounding by bias, as most patients were unable to be blinded by the trial design.  Furthermore, the studies themselves had a high heterogeneity, both in type of lifestyle modification and outcomes followed.  Overall, lifestyle intervention in decreasing the risk of type 2 diabetes among high risk patients is supported by moderate evidence, but its use in patients with disease does not have strong evidence.

By Sai Folmsbee and Aimee Li, MD

More from this author: Combination therapy with tofacitinib improves response in rheumatoid arthritis USPTF recommends tobacco counseling for adolescents by primary care physicians Peer-delivered education through social networking increases home-based HIV testing ACP recommends weight loss and CPAP for obstructive sleep apnea

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: diabetesexercise
Previous Post

Multiple variables related to physical activity levels in preschool children

Next Post

MRA reveals higher prevalence of unruptured cerebral aneurysms than previously reported

RelatedReports

Endocrinology

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

September 10, 2026
Adalimumab aids in control of noninfectious uveitis
Chronic Disease

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

September 8, 2026
Cost-related medication nonadherence associated with increased ED utilization
Pharma

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

September 4, 2026
Weekly Rewinds

2 Minute Medicine Rewind June 29, 2026

June 29, 2026
Next Post
Clinical decision rule highly sensitive in predicting subarachnoid hemorrhage

MRA reveals higher prevalence of unruptured cerebral aneurysms than previously reported

Metoclopramide during pregnancy not associated with birth defects or fetal death

Metoclopramide during pregnancy not associated with birth defects or fetal death

ACGME duty hour regulations linked with decreased perceived quality of care

Regular bedtime helps behavior in children

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar
  • Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma
  • Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.